4//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4
Accession 0001583742-16-000002
$ELTPCIK 0001053369operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:47 PM ET
Size
8.7 KB
Accession
0001583742-16-000002
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2016-08-17+142,857,143→ 142,971,097 total(indirect: see footnote) - Exercise/Conversion
Series I Convertible Preferred Shares
2016-08-17−100→ 0 total(indirect: see footnote)Exercise: $0.00From: 2014-02-07→ Common Stock (142,857,143 underlying)
Holdings
- 21,926,793
Common Stock
- 2,700,000(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]The preferred shares are convertible into shares of common stock at a rate of 1,428,571.43 shares of common stock for each whole share of preferred stock.
- [F2]The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
- [F3]None
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:47 PM ET
- Size
- 8.7 KB